97 related articles for article (PubMed ID: 21545343)
1. Impact of methylation of acyl glucuronide metabolites on incurred sample reanalysis evaluation: ramiprilat case study.
Côté C; Lahaie M; Latour S; Bergeron M; Dicaire C; Savoie N; Furtado M; Garofolo F
Bioanalysis; 2011 May; 3(9):951-65. PubMed ID: 21545343
[TBL] [Abstract][Full Text] [Related]
2. Interference from a glucuronide metabolite in the determination of ramipril and ramiprilat in human plasma and urine by gas chromatography-mass spectrometry.
Persson BA; Fakt C; Ervik M; Ahnoff M
J Pharm Biomed Anal; 2006 Feb; 40(3):794-8. PubMed ID: 16242284
[TBL] [Abstract][Full Text] [Related]
3. Investigation and resolution of incurred sample reanalysis failures: two case studies.
Rocci ML; Collins E; Wagner-Caruso KE; Gibbs AD; Fellows DG
Bioanalysis; 2011 May; 3(9):993-1000. PubMed ID: 21545347
[TBL] [Abstract][Full Text] [Related]
4. Bioanalytical method development and validation using incurred samples--simultaneous quantitation of ramipril and ramiprilat in human EDTA plasma by LC-MS/MS.
Tan A; Jin W; Deng F; Hussain S; Musuku A; Massé R
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov; 877(29):3673-80. PubMed ID: 19782651
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of UPLC tandem mass spectrometry assay for separation of a phase II metabolite of ramipril using actual study samples and its application to a bioequivalence study.
Pudage A; Kamat S
Biomed Chromatogr; 2011 Jun; 25(6):664-73. PubMed ID: 20812207
[TBL] [Abstract][Full Text] [Related]
6. Liquid chromatography-mass spectrometry method for determination of ramipril and its active metabolite ramiprilat in human plasma.
Zhu Z; Vachareau A; Neirinck L
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 779(2):297-306. PubMed ID: 12361743
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous determination of ramipril, ramiprilat and telmisartan in human plasma using liquid chromatography tandem mass spectrometry.
Gupta VK; Jain R; Lukram O; Agarwal S; Dwivedi A
Talanta; 2011 Jan; 83(3):709-16. PubMed ID: 21147310
[TBL] [Abstract][Full Text] [Related]
8. An investigation of incurred human urine sample reanalysis failure.
Fu Y; Li W; Smith HT; Tse FL
Bioanalysis; 2011 May; 3(9):967-72. PubMed ID: 21545344
[TBL] [Abstract][Full Text] [Related]
9. High-performance liquid chromatography-mass spectrometric analysis of ramipril and its active metabolite ramiprilat in human serum: application to a pharmacokinetic study in the Chinese volunteers.
Lu XY; Shen-Tu JZ; Liu J
J Pharm Biomed Anal; 2006 Feb; 40(2):478-83. PubMed ID: 16181761
[TBL] [Abstract][Full Text] [Related]
10. Central nervous and systemic kinetics of ramipril and ramiprilat in the conscious dog.
Nordström M; Abrahamsson T; Ervik M; Forshult E; Regårdh CG
J Pharmacol Exp Ther; 1993 Jul; 266(1):147-52. PubMed ID: 8331554
[TBL] [Abstract][Full Text] [Related]
11. Multiple-dose pharmacokinetics of ramipril in patients with chronic congestive heart failure.
Heintz B; Verho M; Brockmeier D; Lückel G; Maigatter S; Sieberth HG; Rangoonwala B; Bender N
J Cardiovasc Pharmacol; 1993; 22 Suppl 9():S36-42. PubMed ID: 7514239
[TBL] [Abstract][Full Text] [Related]
12. Impact of oxcarbazepine sulfate metabolite on incurred sample reanalysis and quantification of oxcarbazepine.
Dicaire C; Bérubé ER; Dumont I; Furtado M; Garofolo F
Bioanalysis; 2011 May; 3(9):973-82. PubMed ID: 21545345
[TBL] [Abstract][Full Text] [Related]
13. Incurred sample reanalysis (ISR): a decisive tool in bioanalytical research.
Yadav M; Shrivastav PS
Bioanalysis; 2011 May; 3(9):1007-24. PubMed ID: 21545349
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme inhibition in cirrhotic patients--pharmacokinetics of ramipril.
Pidlich J; Cichini GM; Reinisch W; Peck-Radosavljevic M; Renner F
Acta Med Austriaca; 1997; 24(1):15-8. PubMed ID: 9150805
[TBL] [Abstract][Full Text] [Related]
15. GlaxoSmithKline's experience of incurred sample reanalysis for dried blood spot samples.
Barfield M; Ahmad S; Busz M
Bioanalysis; 2011 May; 3(9):1025-30. PubMed ID: 21545350
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of ramipril and ramiprilat in healthy cats.
Desmoulins PO; Burgaud S; Horspool LJ
J Vet Pharmacol Ther; 2008 Aug; 31(4):349-58. PubMed ID: 18638296
[TBL] [Abstract][Full Text] [Related]
17. Incurred sample accuracy assessment: design of experiments based on standard addition.
de Boer T; Wieling J
Bioanalysis; 2011 May; 3(9):983-92. PubMed ID: 21545346
[TBL] [Abstract][Full Text] [Related]
18. Incurred sample reanalysis: failures in macromolecule analysis--insight into possible causes.
Sailstad JM; Salfen BE; Bowsher RR
Bioanalysis; 2011 May; 3(9):1001-6. PubMed ID: 21545348
[TBL] [Abstract][Full Text] [Related]
19. Beyond successful ISR: case-by-case investigations for unmatched reassay results when ISR passed.
Tan A; Gagnon-Carignan S; Lachance S; Boudreau N; Lévesque A; Massé R
Bioanalysis; 2011 May; 3(9):1031-8. PubMed ID: 21545351
[TBL] [Abstract][Full Text] [Related]
20. Preliminary results of biliary excretion of ramipril after T-drainage in cholecystectomy patients.
Luck C; Verho M; Umscheid T; Stelter WJ; Ziegler HP
J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S116-21. PubMed ID: 1725018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
